NH House Testimony

SB256

Senate · 2026 sessionRepublicanInterim study

Safety rules for clinician-administered drugs

AI

Establishes safety and procedural requirements governing the administration of clinician-administered drugs.

(New Title) establishing safety and care requirements for clinician-administered drugs.

Public and Mental HealthOccupational Regulation

Status

Referred to interim study (House) · May 14, 2026
  1. Introduced
  2. Senate
  3. House
  4. Governor
  5. Law

Division of testimony

3 submissions
Support 2Oppose 1Neutral 0
Sam HallemeierOpposeWashington, DC, DCfor PCMAApr 7, 2026

Position recorded without written comment.

Nicholas TelescoSupportAlexandria, VAfor NNECOS and ASCOApr 7, 2026

Position recorded without written comment.

Cory StoneSupportDOVER, NHfor MyselfApr 7, 2026

Position recorded without written comment.